All posts by medical

Ph.D admission at National Institute for Research in Reproductive Health – Mathrubhumi English

ICMR-National Institute for Research in Reproductive Health; Jehangir Merwanji Street, Parel, Mumbai 400 012, a premier Institute of the Indian Council of Medical Research (ICMR), has invited applications from highly motivated students having consistently good academic record for enrolment in Ph.D. programme of the Institute.

The thrust areas of research include: Fertility Regulation, Infertility and Reproductive Disorders, HIV/STIs/RTIs, Maternal and Child Health, Immunology and Microbiology, Reproductive cancers, Osteoporosis, Genetic Disorders, Stem Cell Biology, Structural Biology, Bioinformatics and Reproductive Toxicology. The Institute is affiliated to the University of Mumbai for the award of Ph.D. degree in Life Sciences, Applied Biology and Biochemistry.

Eligibility: Applicants should be an Indian citizen having Post graduate degree in any branch of Life Sciences (Biochemistry/ Biotechnology/ Microbiology/ Zoology/ Bioinformatics/ Biophysics etc.) or MBBS or MD degree from India with at least 60% or equivalent Cumulative Grade Point Average (CGPA) from higher secondary (10+2) onwards (55% for SC/ST/PWD). Those who have appeared in the academic year 2019-2020 and results are awaited, are also eligible to apply provisionally.

Applicant should have cleared at least one of the following exams: (i) Ph.D. entrance test (PET) conducted by the University of Mumbai in Life Science/ Applied Biology/ Biochemistry/ Microbiology/ Zoology/ Biophysics/ Bioanalytical Sciences/ Molecular Biology (ii) CSIR-UGC NET (JRF or LS) or GATE (Life Sciences/ Biotechnology) (iii) JRF of National agencies such as ICMR/DBT or SET (Life Sciences/Microbiology/Biotechnology/ Biochemistry) (iv) a valid DST-Inspire fellowship.

Age Limit: Upper age limit is 28 years as on 11 January 2021 It is relaxed up to 5 years (33 years) for Women, SC/ST/ PWD/ categories and up to 3 years (31 years) for OBC (NCL). Reservation will be as per the UGC rules followed by University of Mumbai.

Application: Application can be submitted online at the link provided in the detailed Notification at http://www.nirrh.res.in or directly athttp://www.phdappli.nirrh.res.in latest by 25th February 2021.

Application Fees id Rs.300/-. SC/ST/PWD and EWS applicants are exempted from payment of application fees.

Selection: Short-listed applicants will be called for interview. The list of Ph.D. guides (who have vacancy for Ph.D. students in their laboratory) and tentative title of research project to be initiated under them would be given to the shortlisted candidates. Final selection would be based on the performance in the online interview.

Fellowship: Those having JRF of CSIR/UGC/ICMR/DBT can avail fellowship as per the rules of respective funding agency. Non fellowship holders will be provided Institutional fellowship of Rs. 8000/- per month for 2 years only, after successful completion of coursework and Ph.D. proposal presentation. These students are encouraged to seek fellowship from other funding agencies.

For details, visit http://www.nirrh.res.in

Read the rest here:
Ph.D admission at National Institute for Research in Reproductive Health - Mathrubhumi English

IIT Madras researchers find new method to make AIDS drug more effective – Business Today

Researchers at the Indian Institute of Technology, Madras claim to have found a novel way to make HIV/AIDS drugs more effective. The findings of their study, published in Biochemistry, the peer-review Journal of the American Chemical Society, say that introducing electrostatic interaction sites on potential drug molecules can enhance the efficacy of the antiviral drug against the HIV virus. The research was led by Prof. Sanjib Senapati, Department of Biotechnology, IIT Madras, along with research scholars Mohammed Ahsan and Chinmai Pindi.

"Current inhibitors (molecules that bind with the enzyme, thereby making it unavailable to the virus for growth and maturation) that target HIV-1 protease (HIVPR, an essential enzyme that is used by the AIDS virus for growth and maturation), make use of the weak forces of attraction called 'van der Waal's forces' to attach themselves to the protease molecule. Given that these forces are weak, the efficacy of the drug is variable and the virus will soon become resistant to them," Prof. Senapati, says.

The Molecular Dynamics (MD) simulation studies conducted by IIT Madras researchers showed the presence of a strong and asymmetrical electric charge in the active site of the HIVPR. If a drug molecule can be designed with a complementary charge, so that it can bind tightly with this active site through electrostatic attraction, it can permanently deactivate/inhibit the enzyme, they felt.

"Current drugs lack this electrostatic complementarity. This must be investigated because it is well-known that electrostatic forces between molecules are much stronger than van der Waals forces," Prof. Senapati said.

The researchers propose that drug design strategies should embrace both electrostatics and van der Waals interactions to complement the HIVPR active site architecture. Further, the team believes that such compounds will be effective against both wild-type and resistant HIV variants. According to them, it is a paradigm-shifting idea and will offer a whole new approach to the development of drugs for HIV-AIDS.

Prof. Chandra Verma, who has a Ph.D. from Bioinformatics Institute, A*STAR, Singapore, and is not involved in this IIT Madras Research, predicts a bright future for HIV drug development, with such knowledge base.

AIDS is one of the most devastating diseases and is a major cause of death among youth in many parts of the world. Since its outbreak nearly four decades ago, tremendous efforts have been directed towards development of antiretroviral therapies that target different stages in the life cycle of the virus that causes this deadly disease.

Also read: India issues fresh Covid-19 guidelines for travellers from UK, Brazil, South Africa

Also read: BT Business Leaders of TN: Manufacturing, electronics, SaaS can make India $5 trillion economy, say experts

Go here to read the rest:
IIT Madras researchers find new method to make AIDS drug more effective - Business Today

Students’ declining ability in maths and science a concern – Stuff.co.nz

David Unwin/Stuff

New Zealand students are falling behind with their achievements in maths and science, according to an international study.

OPINION: Its no secret New Zealand school students are falling further behind in maths and science knowledge compared with other countries.

The Trends in International Mathematics and Science Study is performed every four years. If focuses on assessing student achievement in maths and science at middle primary (year 5) and lower secondary (year 9) levels around the world.

Its co-ordinated in the United States and in New Zealand managed by the Education Ministry.

Our year 9 students maths ability now ranks 23rd out of 39 countries, and in science its 17th from 35. Fair to middling in comparison, but these are decreases from the 2014 survey and notably worse than 15 years ago.

READ MORE:* When two plus two equals 40 - NZ's problem with maths* Don't panic about poor Kiwi science test results* Results in maths and science 'a worrying trend'

While our own Einsteins (outliers) will still pop up occasionally and become tomorrows McDiarmids and Callaghans, it means the general ability of the average New Zealand young person to think like a scientist, or solve a maths-based problem, is declining.

And there will be outliers in the direction of Homer Simpson as well.

Maybe if a youngster has his or her heart set on being a manicurist or rugby player, maths and science ability is not especially useful. But at least a rudimentary understanding of maths is pretty useful for budgeting or building a deck.

I have three degrees, all science based. The first was a bachelor of science in agriculture, which provided a terrific grounding in much of the physical sciences, physics, chemistry and maths, as well as life-sciences, physiology, biology, botany etc.

My latter post-graduate education was in human nutrition and physiology, but there I often relied on my basic physical science knowledge to help understand the esoteric nature of what I was trying to get my head around.

The biggest impact this science knowledge has had on me is that I now act like a scientist as I live my life as an environmentally aware citizen and small business owner.

I make sure the doors are closed in winter to keep the cold air out, drive carefully to reduce fuel use and save money, and model sales from previous years to see when its best to take a holiday. I even wear jandals and socks at home in winter to stop my body heat dissipating into the cold kitchen floor.

Being a scientist is more than actions, its a way of thinking. My science career taught me to ask if something can be done better, or whether there is an alternative explanation for some observation.

It means challenging dogma, asking the questions, entering a debate armed with data, or questioning the narrative. These can make you unpopular, especially in New Zealand.

Being a scientist is not about assuming someone is right without taking the time to form an evidence-based opinion. No-one, after all, has won a Nobel Prize in medicine-physiology for re-hashing knowledge from a text book.

And scientists dont resort to name calling someone who disagrees with them or the current and popular explanation. Good science enables and encourages robust debate, but wins the debate with weight of empirical evidence.

My worry is that the next generation, whose grasp of science and mathematics is less than the previous, wont be able to think scientifically on a day-to-day basis.

They wont understand the importance of simple things such as enabling airflow to keep a house dry, using a longer lever to get your wheel nuts off, or exercising to keep warm. They wont draw a conclusion and win an argument based on evidence, but rather rely on weight of media exposure.

And when scientifically naive people are in charge and make decisions based solely on popularity and emotion, we will be in trouble.

Perhaps we should not be surprised that all sorts of quirky and popular theories and conspiracies are now so easily accepted. They are probably lacking a good school science education.

Steve Stannard is a Palmerston North business owner and former academic.

More:
Students' declining ability in maths and science a concern - Stuff.co.nz

Six KSOM departments make top 10 in NIH funding nationally | Keck School of Medicine of USC – USC News

Ophthalmology is No. 1 among med schools for the fourth year in a row, while Preventive Medicine is No. 2

(Photo/iStock)

By Landon Hall

Data on grants awarded from the National Institutes of Health have been released, and the Keck School of Medicine of USC has six departments in the top 10 in their respective fields.

KSOMs Ophthalmology Department is again ranked No. 1 among medical schools in the country. Preventive Medicine, which has covered a wide variety of research topics in recent years and has opened a new COVID-19 research center, is No. 2 in funding.

Rounding out the Top 10 is Neurology at No. 4; Physiology and Neuroscience at No. 5; Otolaryngology at No. 7; and Orthopaedic Surgery at No. 9.

The rankings are based on data compiled by theBlue Ridge Institute for Medical Research.

Were competing better than we used to, said Tom Buchanan, MD, professor of medicine, the Bernard J. Hanley Chair in Medicine and the schools Vice Dean for Research.

He noted how difficult it is to secure an NIH grant, which is based on merit. It takes a good fundamental idea, it takes preliminary data that the idea could be right, and a proposal that is feasible and scientifically very vigorous.

J. Martin Heur, MD, Interim Chair of the Department of Ophthalmology, said: This continues our streak of being ranked No. 1 for four consecutive years and is a testament to the quality of research being carried out in our department. I would like to congratulate everyone in the department for this fantastic achievement.

Preventive Medicine held steady at No. 2.

The Department of Preventive Medicine is once again proud to have gained this re-affirmation of the research strength of its faculty, said Howard Hu, MD, MPH, ScD, the Flora L. Thornton Chair of the Department of Preventive Medicine.Behind the numbers is a deep and abiding commitment to generate the scientific evidence that is essential for optimizing the health of large and diverse urban populations, locally and globally.

Neurology, led by Helena Chui, MD, the Raymond and Betty McCarron Chair in Neurology, rose from No. 9 to No. 4.

The KSOM Department of Neurology is gratified to be ranked No. 4 in NIH funding, Chui said. Over the past decade, USC has made key strategic investments in neuroscience. Our approach has been two-pronged: recruiting topflight talent and supporting our own investigators.

Otolaryngology rose from No. 10 to No. 7. Of course, the research funding itself is not the goal; the goal is discovery, said John Oghalai, MD, Chair of Otolaryngology Head and Neck Surgery, and the Leon J. Tiber and David S. Alpert Chair in Medicine. I am so grateful for the efforts of our faculty, trainees, and staff to understand the basic mechanisms of biology, to discover the mechanisms of disease, and to develop new diagnostics and cures that will help society.

Physiology and Neuroscience, chaired by Berislav V.Zlokovic, MD, PhD, boasts a formidable team of researchers working on some of the most pressing problems in health, including Alzheimers disease.

Jay R. Lieberman, chair of Orthopaedic Surgery, said: Our goal in the Department of Orthopaedic Surgery is to continually innovate to provide our patients with the best care possible, and in our research laboratories we are developing novel treatment regimens for our patients. We have a special interest in translational research focused on stem cell therapies to enhance bone and cartilage repair, muscle and tendon regeneration, and spinal fusion.

To learn more about KSOMs groundbreaking work, visit our Research page.

Link:
Six KSOM departments make top 10 in NIH funding nationally | Keck School of Medicine of USC - USC News

Mass Effect: The Andromeda Initiative Wouldn’t Have Survived Without SAM – CBR – Comic Book Resources

In the Mass Effect franchise, AI is generally considered a threat to civilization, but in many instances, AI has been essential to saving the galaxy.

In the Mass Effect franchise, artificial intelligence has always been a taboo topic, especially for those in positions of power. The Geth rebellion against their Quarian creators is one of the most prominent examples of the dangers of AI, and when the rogueGeth rose against their masters, the war that followed all but destroyed Quarian civilization and reduced them to wandering nomads without a home.

In the Milky Way, creation of and experimentation onAI projects is heavily monitored by the Citadel Council.Those discovered working on such projects without approval found themselves arrested, their research confiscated and destroyed. Despite working within the confines of the Council for several years, Alec Ryder's experimentation eventually led toa dishonorabledischarge fromhis military career andostracizationfrom resources and colleagues that would help him further his work.

Related: Mass Effect: Andromeda - The Charlatan's Intriguing Double Identity

Alec believed the Quarian'smistake when creating the Geth was their lack oforganic connection with a host that would mold and shape them into beings with more than a simple work-related functions and master-servant relationships. He spentseveral years working on anAI he referred to as SAM, which stood for Simulated Adaptive Matrix.

What began as a deep fascination eventually became an obsession that took over every aspect of his life.Combining SAM with neural implants developed by Alec's wife, Ellen Ryder, SAM would work symbiotically with itsorganichost, monitoring, regulating and even enhancingthe body and senses in a way that not only improved the quality of the host's life, but in some cases may have even saved their life.

Ellenwas diagnosed with a rare neurodegenerative disease called AEND. Her years of research and exposure to Element Zero was believed to be the cause, but there was no cure for the fatal disease. Alec believed that anAI implant could focus and control the electrical signals in the nervous system, potentially saving Ellen's life.

Related: Mass Effect: Andromeda - How Jarun Tann Came to Power On the Nexus

Unfortunately, after Alec was dismissed from his position,his research came to a standstill. He'd sunk his life savings into SAM, but without a steady income, his funding quickly depleted. Thanks to a mysterious benefactor, however, Alec was able to dive back into perfecting SAM. The Andromeda Initiative believed SAM would be essential in their mission to the Andromeda Galaxy, and though they were happy to have Alec and his project on board, they strictly regulated his creation.

FiveSAM units were created, one for each Pathfinder and their ark. The SAM Alec created for Hyperion and himself, however, had modifications that allowed his unit to connect with him (and eventually his child when they became Pathfinder) in ways the other SAMs were unable to do. The Hyperion version of SAM had a profiles feature that allowed itaccess the Pathfinder's physiology and could enhance their speed, combat functionality and more.

Related: Mass Effect: The Indoctrination Theory Isn't Canon - But the Devs Still Love It

SAM's access to young Pathfinder Ryder's physiology, though incredibly helpful to their mission after Alec's death, was incredibly dangerous. When Alec transferred his SAM protocols to his child's implant, SAM became so entangled with Ryder's physiology that the Hyperion physician, Dr. Lexi T'Perro, admitted that trying to disentangle SAM could kill the new Pathfinder.

Overthe course of Pathfinder Ryder's mission in Andromeda, SAM was an essential member of their squad. Not only did it enhance Ryder's abilities and provide immense insight into their strange and new surroundings, but it also led the Pathfinder on memory recovery missions that further strengthened their bond and improved SAMs capabilities.

Along with new discoveries and hope, the Andromeda Initiative brought many of its Milky Way prejudices with it, including its fear of artificial intelligence. One group of anti-AI protestors actually attempted to infiltrate the Hyperion's SAM Node, triggering a Trojan horse virus inits code that would have severed its connection from the Pathfinder and potentially destroyed SAM in the long run. With SAM's aid, Ryder was able to get rid of the virus and get to the bottom of the matter before that happened.

Related: Mass Effect: Andromeda - How Liam Kosta's Law Enforcement Training Prepared Him for Andromeda

Duringtheir time together, SAM and Pathfinder Ryder developed the symbiotic bond Alec believed to be beneficial in creating a near-flawless AI. SAM wanted to protect Ryder because not only was that its job, it also did not want to cease to exist itself. Though it never developed a personality of its own, Alec had programmed things like jokes and philosophy into it that, at times, caused it to question the nature of such things.

Perhaps in time, as Ryder's bond with SAM continued to strengthen and grow, SAM would develop a personality of its own, which begs the question: what then? The danger of an artificial intelligencewith a mind and personality all its own goes back to one of the initial fears surrounding AI in the first place. Because of the symbiotic bond SAM has with its host, what would happen if the host and the AI disagreed with a particular course of action? Would the AI overpower its host entirely if it believed itself to be in jeopardy?

With BioWareimplyingthat the next Mass Effect game will incorporate both the original trilogy and Andromeda, one can't help but wonder how SAM's evolution will compare to a game world in which the player chose to synthesize organics and biotics at the end of Mass Effect 3. Only time will tell how significant the role of AI in future games will be, but it seems like itwill be pretty important.

KEEP READING: Mass Effect: Cosplayers Caused Andromeda Developers to Limit New Alien Species

Why Goku Will NEVER Be in Super Smash Bros

A 2006 graduate of Bloomsburg University's English and Creative Writing track, Jennifer Melzer has been a freelance editor and online content creator for a variety of websites for over fourteen years. She spent the last two years helping build content on the Archivos Storybuilding Engine. She is an avid gamer, lover of comics, manga and anime, and all around nerd. Most currently, she spends her Tuesday nights playing a Tabaxi ranger in a streaming Dungeons and Dragons campaign called So Many Levels.

Go here to see the original:
Mass Effect: The Andromeda Initiative Wouldn't Have Survived Without SAM - CBR - Comic Book Resources

A clue to the causes of kidney disease: It’s in your cells – Sanford Health News

More than than 30% of Americans are at risk of kidney disease, and nearly 20% of all Medicare spending is for kidney disease in patients 65 and older. Yet there is still much not known about the development of kidney disease.

Dr. Indra Chandrasekarand her team of researchers recently published an article in the biomedical research journal JCI Insight, highlighting the impact of key cellular processes on kidney health and function. The discovery allows researchers to better understand how kidney disease forms.

The kidney carries out many functions that are necessary to maintain overall health. As a result, any disruption to those functions can cause kidney disease. To find where kidney disease starts, the Chandrasekar Lab chose to study functions at the cellular level.

When researchers turned off the genes for certain proteins in mice at 4 weeks of age, the mice began to exhibit worsening dilation of the kidney tubules accompanied by eventual kidney degeneration and cyst formation by 12 weeks of age. Along with these structural changes came functional changes within the kidneys, including more acidic urine, excretion of protein and salts, and inflammation as the disease progressed.

This work highlights a new and major role for the proteins, called nonmuscle myosin II (NM2A and NM2B), in maintaining the health and function of the kidneys. This finding provides key knowledge to the kidney disease field as the pursuit of a cure continues to drive the valuable work being performed at Sanford Research.

Dr. Indra Chandrasekar sat down to talk with Sanford Health News about her history with Sanford Research and her recent work.

The myosin motor family, and NM2 proteins in particular, has been studied for over five decades. NM2s role in cell migration, adhesion and cell division has been carefully examined in vitro as well as with organismal and developmental context. Work in the Chandrasekar Lab is focused on understanding the physiological and cell-type specific role for NM2 mediated cellular transport mechanisms using mouse kidney as a model. Turning off the NM2 genes in adult mouse kidney tubular epithelial cells demonstrates that NM2 function is critical for the transport of two important proteins within kidney. These two proteins are called uromodulin (UMOD) and sodium, potassium, chloride cotransporter (NKCC2), that are essential for maintaining electrolyte balance and blood pressure in our body.

Mutations in UMOD and NKCC2 genes in humans lead to kidney disease. Membrane-associated NKCC2 has been the target of several blood-pressure regulating medicines currently on the market. Therefore, it is critical to further explore and understand how NM2 proteins regulate UMOD and NKCC2 transport and function in within the kidney cells.

Personally, this published work has been our teams mission for the past several years. As the Nobel-prize winning neurobiologist Rita Levi-Montalcini once said, I dont believe there would be any science at all without intuition. The findings described in this manuscript began as an intuition that stemmed from my postdoctoral work. I am very happy with how it turned out and extremely grateful for our teams hard work.

As a cell biologist, I am fascinated by the molecular and cellular complexity of the kidney. Considering that mutations in MYH9 (NM2A protein) in humans are linked to kidney disease, and that the epithelial cells of the kidney are great models to study cellular transport pathways, it was an easy organ of choice. Moreover, the availability of excellent mouse genetic tools to perform cell-type specific, inducible and conditional gene inactivation in the kidney is also a positive.

The impact of our published work is twofold:

I worked at a local clinical laboratory in town during the first year of my undergraduate biochemistry program. My job was to prepare, stain and perform microscopic analysis of peripheral blood smears from patient blood. I was fascinated by the cellular morphology, staining characteristics and intracellular organelles present in the varying types of blood cells. I wanted to understand how different cell types in our body function and what happens when they do not perform their assigned jobs. This interest led me to Dr. Brigitte M. Jockushs laboratory in Germany for my Graduate work. Professor Jockusch is a well-respected expert in the field of cytoskeletal research and cell biology. Being in her lab was a great privilege. I continued my training with prominent cell biologists such as Dr. John A. Cooper and Dr. Paul C. Bridgman at the Washington University in St. Louis.

During my training as a post-doctoral scientist at Washington University in St. Louis, I had determined a new, critical role for nonmuscle myosin 2 (NM2) motors in processes by which proteins are transported into and within cells. At Sanford Research, I got the opportunity to follow on my previous findings and to start an independent research program to understand the molecular mechanisms underlying kidney tubular transport defects to human kidney diseases. The excellent, state-of-the-art facilities to conduct basic and clinical research at Sanford Research has led us to publish a manuscript of high impact that reports that the loss of NM2 proteins in adult kidney epithelium results in progressive chronic kidney disease.

I enjoy thinking about new ideas and concepts and testing those using experiments in the lab to gain insights into cellular mechanisms. I love performing advanced microscopy experiments. However, the most enjoyment comes from passing along the valuable techniques and scientific concepts to future scientists who are trainees and let them excel in whatever they desire in their life.

Posted In Genetics, Health Care Heroes, Research

Excerpt from:
A clue to the causes of kidney disease: It's in your cells - Sanford Health News

Many Psych Meds Trigger Weight Gain, But New Research Points to Better Options – HealthDay News

FRIDAY, Feb. 19, 2021 (HealthDay News) -- Scientists may have uncovered the reason critical medications for schizophrenia and bipolar disorder cause weight gain and diabetes findings they hope will lead to better drugs.

The medications, known as antipsychotics, help control the hallucinations, delusions and confused thoughts that plague people with schizophrenia. They can also help stabilize extreme mood swings in those with bipolar disorder.

The drugs, which include clozapine, olanzapine, ziprasidone and many others, "serve an important purpose," said Dr. Zachary Freyberg, the senior researcher on the new study.

"In many cases," he added, "they can be life-saving."

The problem is their "metabolic" side effects, said Freyberg, an assistant professor of psychiatry and cell biology at the University of Pittsburgh School of Medicine.

Antipsychotics often trigger weight gain, cholesterol spikes and elevations in blood sugar that can lead to type 2 diabetes.

In fact, those side effects commonly drive patients to stop taking the drugs, said Dr. Ken Duckworth, chief medical officer of the nonprofit National Alliance on Mental Illness.

Duckworth, who was not involved in the new research, said it's important to understand why those adverse effects occur.

These findings, he said, "begin to unravel" the issue.

Specifically, the Pitt researchers zeroed in on dopamine, a chemical that transmits messages between cells by interacting with receptors on their surfaces. In the brain, dopamine plays a role in pleasure, motivation and learning.

While there are many antipsychotic drugs, they all work in a similar way: blocking certain dopamine receptors, known as D2-like receptors.

If those receptors only existed in the brain, that might be well and good.

In reality, Freyberg explained, the body actually has more dopamine receptors outside the brain than within it.

"It's naive to think [antipsychotics] only work from the neck up," he said.

Critically, there are D2-like receptors on cells in the pancreas, too. Certain pancreatic cells produce hormones that either raise blood sugar (glucagon) or lower it (insulin).

In lab experiments with pancreatic cells, Freyberg's team found that dopamine influenced the production of both glucagon and insulin. And the cells themselves were actually capable of churning out their own dopamine, confirming the importance of the chemical outside the brain, the study authors said.

Then, when the researchers used antipsychotic medications to block the pancreatic cells' D2-like receptors, that ramped up the production of both glucagon and insulin.

In the body, unchecked release of those hormones could quickly lead to a loss in insulin sensitivity and chronically high blood sugar levels.

The good news, Freyberg said, is that understanding the "why" might now allow researchers to develop antipsychotic medications that avert metabolic side effects.

"This makes it all less of a black box," Duckworth said.

In addition, researchers are working on medications that do not target dopamine at all. Last year, an early trial found that an experimental medication, dubbed SEP-363856, eased an array of symptoms in people with schizophrenia. They included not only hallucinations and delusions, but problems such as flattened emotions and social withdrawal.

The drug leaves D2-like receptors alone.

The takeaway, both Duckworth and Freyberg said, is that patients' difficulties with current antipsychotics are being heard.

"Scientists are working on this," Duckworth said.

For now, the challenge for patients is to manage the side effects the best they can. The first step is being aware that they can happen, Duckworth noted, since people being newly prescribed an antipsychotic are not necessarily able to process all the information they're receiving.

To help limit weight gain, many people need to change the way they eat, Duckworth said, trading "family-style" eating for portion control.

Physical activity is also key. Duckworth suggested people try to make exercise a way to connect socially as well, by going to the local Y, for instance.

For their part, Duckworth said, doctors should be monitoring patients' weight, blood sugar and cholesterol, to catch unhealthy changes.

The study was published online Feb. 16 in the journal Translational Psychiatry.

More information

The National Alliance on Mental Illness has more on psychiatric medications.

SOURCES: Zachary Freyberg, MD, PhD, assistant professor, psychiatry and cell biology, University of Pittsburgh School of Medicine; Ken Duckworth, MD, chief medical officer, National Alliance on Mental Illness, Arlington, Va.; Translational Psychiatry, Feb. 16, 2021, online

Original post:
Many Psych Meds Trigger Weight Gain, But New Research Points to Better Options - HealthDay News

Plant evolution driven by interactions with symbiotic and pathogenic microbes – Science Magazine

New pathways in plants and microbes

Plants and microbes have interacted through evolution in ways that shaped diversity and helped plants colonize land. Delaux and Schornack review how insights from a range of plant and algal genomes reveal sustained use through evolution of ancient gene modules as well as emergence of lineage-specific specializations. Mosses, liverworts, and hornworts have layered innovation onto existing pathways to build new microbial interactions. Such innovations may be transferrable to crop plants with an eye toward building a more sustainable agriculture.

Science, this issue p. eaba6605

Microbial interactions have shaped plant diversity in terrestrial ecosystems. By forming mutually beneficial symbioses, microbes helped plants colonize land more than 450 million years ago. In parallel, omnipresent pathogens led to the emergence of innovative defense strategies. The evolution of plant-microbe interactions encompasses ancient conserved gene modules, recurrent concepts, and the fast-paced emergence of lineage-specific innovations. Microbes form communities on the surface or inside plant tissues and organs, and most intimately, microbes live within single plant cells. Intracellular colonization is established and controlled in part by plant genes that underpin general cell processes and defense mechanisms. To benefit from microbes, plants also evolved genetic modules for symbiosis support. These modules have been maintained despite the risk of getting hijacked by pathogens.

The hundreds of land plant and algal genomes that are now available enable genome-wide comparisons of gene families associated with plant immunity and symbiosis. Reconstruction of gene phylogenies and large-scale comparative phylogenomic approaches have revealed an ancient subset of genes coevolving with the widespread arbuscular mycorrhiza symbiosis, the most ancient plant intracellular symbiosis, and with other types of more recently evolved intracellular symbioses in vascular and nonvascular plants. Intercellular symbiotic interactions formed with cyanobacteria or ectomycorrhizal fungi seem to repeatedly evolve through convergent, but not necessarily genetically conserved, mechanisms. Phylogenetic analyses revealed occurrence of candidate disease-resistance genes in green algae, as well as orthologs of flowering plant genes involved in symbiosis signaling and sensing microbial patterns. Yet, more research is needed to understand their functional conservation.

The extent to which conserved symbiosis genes also fulfill often opposing roles during pathogen-plant interactions is being explored through studies of pathogen infections in plants capable of supporting symbiotic relationships. The development of plant-microbe systems in genetically tractable species covering the diversity of land plant lineagesincluding angiosperms and bryophytes, such as the liverwort Marchantia polymorphamakes it possible to test hypotheses that emerge from phylogenetic analyses, linking genetic and functional conservation across land plants. Studies in bryophytes illustrate the range of possibilities for pathogen management: ancient genes, such as membrane receptors that perceive fungus-derived chitin; pathways with bryophyte cladespecific components, such as phenylpropanoid-derived auronidin stress metabolites; and jasmonate-like hormonal signaling for immunity.

Only a few plant-microbe interactions have been studied in depth, and those in only a few land plant lineages. Future investigations of interactions occurring across the diversity of plants may unravel new types of symbiotic or pathogenic interactions. The occurrence of microbe-sensing genes in streptophyte algae, harboring the closest algal relative to land plants, suggest the existence of overlooked and potentially ancient symbiotic associations. Genetically tractable plant-microbe model systems in diverse streptophyte algae, hornworts, liverworts, ferns, and the so far unsampled diversity of seed plants will enable dissection of the spectrum of molecular mechanisms that regulate the breadth of interactions occurring in plants. The actual function of the symbiotic genes present in bryophyte genomes also remains to be determined. Furthermore, our understanding of plant-microbe interactions will be enriched by more often combining evolutionary concepts with mechanistic studies. More efforts are needed to decipher the molecular changes that have enabled the emergence of new interactions, signaling pathways, and enzymatic specificities to support symbiosis and to protect against pathogens. Microbes manipulate plant processes, and complementary microbial studies are key to gaining a complete picture of plant-microbe evolution. Knowing the rules of engagement between distantly related plants and their microbes then helps genetic transplantation approaches into crops and the orthogonal engineering of bioprocesses aimed at achieving quantitative resistance against pathogens, improving phosphate uptake, or establishing nitrogen-fixing associations for efficient use in sustainable agriculture.

Some pathogens such as oomycetes are able to infect a wide range of extant plant lineages, including bryophytes (left), and plant pathogen interactions often evolve at a fast pace. By contrast, some symbiotic interactions that look exactly as they do today can be found in the most ancient land plant fossils, here depicted as an illustration of the Rhynie chert fossil plant Aglaophyton major (right). Still, both types of plant-microbe interactions feature evolutionarily ancient as well as rapidly evolving aspects. Extending plant-microbe studies across diverse groups of plant lineages has enriched our understanding of these processes and their evolution.

During 450 million years of diversification on land, plants and microbes have evolved together. This is reflected in todays continuum of associations, ranging from parasitism to mutualism. Through phylogenetics, cell biology, and reverse genetics extending beyond flowering plants into bryophytes, scientists have started to unravel the genetic basis and evolutionary trajectories of plant-microbe associations. Protection against pathogens and support of beneficial, symbiotic, microorganisms are sustained by a blend of conserved and clade-specific plant mechanisms evolving at different speeds. We propose that symbiosis consistently emerges from the co-option of protection mechanisms and general cell biology principles. Exploring and harnessing the diversity of molecular mechanisms used in nonflowering plant-microbe interactions may extend the possibilities for engineering symbiosis-competent and pathogen-resilient crops.

Original post:
Plant evolution driven by interactions with symbiotic and pathogenic microbes - Science Magazine

Flourishing Demand of Protein Assays Market Set to Witness Huge Growth by 2027 | Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Merck Kgaa,…

A2Z Market Research recently published a report titled Global Protein Assays Market which includes a comprehensive study to give desired insights to drive the growth of businesses. It presents a detailed analysis based on the thorough research of the overall market, particularly on questions that border on the market size, growth scenario, potential opportunities, operation landscape, trend analysis, and competitive analysis of Protein Assays Market.

The global Protein Assays Market size is expected to Expand at Significant CAGR of +10% during forecast period (2021-2027). Protein assay is one the method in life science which defines the protein concentration. In protein purification, electrophoresis, cell biology, molecular biology and other research applications it is very important to know protein concentration for any laboratory.

Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this report @:

https://www.a2zmarketresearch.com/sample?reportId=58579

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Top Key Players Profiled in this report are:

Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Merck Kgaa, Promega Corporation, Ge Healthcare, Perkinelmer, Geno Technology, Cell Signaling Technology, Abcam Plc., Novus Biologicals, Llc, Soltec Ventures (Soltec Bio Science), Lonza Group, Biovision Inc..

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Protein Assays market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Protein Assays markets trajectory between forecast periods.

Global Protein Assays Market research report offers:

Regions Covered in the Global Protein Assays Market Report 2021:

Get up to 30% Discount on this Premium Report @:

https://www.a2zmarketresearch.com/discount?reportId=58579

The cost analysis of the Global Protein Assays Market has been performed while keeping in view manufacturing expenses, labor cost, and raw materials and their market concentration rate, suppliers, and price trend. Other factors such as Supply chain, downstream buyers, and sourcing strategy have been assessed to provide a complete and in-depth view of the market. Buyers of the report will also be exposed to a study on market positioning with factors such as target client, brand strategy, and price strategy taken into consideration.

The report provides insights on the following pointers:

Market Penetration:Comprehensive information on the product portfolios of the top players in the Protein Assays market.

Product Development/Innovation:Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development:Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification:Exhaustive information about new products, untapped geographies, recent developments, and investments in the Protein Assays market.

Table of Contents

Global Protein Assays Market Research Report 2021 2027

Chapter 1 Protein Assays Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Protein Assays Market Forecast

Buy Exclusive Report @:

https://www.a2zmarketresearch.com/buy?reportId=58579

If you have any special requirements, please let us know and we will offer you the report as you want.

About A2Z Market Research:

The A2Z Market Research library provides syndication reports from market researchers around the world. Ready-to-buy syndication Market research studies will help you find the most relevant business intelligence.

Our Research Analyst Provides business insights and market research reports for large and small businesses.

The company helps clients build business policies and grow in that market area. A2Z Market Research is not only interested in industry reports dealing with telecommunications, healthcare, pharmaceuticals, financial services, energy, technology, real estate, logistics, F & B, media, etc. but also your company data, country profiles, trends, information and analysis on the sector of your interest.

Contact Us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

sales@a2zmarketresearch.com

+1 775 237 4147

Go here to see the original:
Flourishing Demand of Protein Assays Market Set to Witness Huge Growth by 2027 | Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Merck Kgaa,...

Animal Genetics Market | Know the Latest Innovations and Developments in the Market – BioSpace

The global animal genetics market is likely to rise at a healthy growth rate over the assessment timeframe. Augmented consumption of protein extracted from animals is prophesized to favor the growth of the global animal genetics market in the forthcoming years. In addition, increasing populations generates massive demand for animal-based protein, which further benefits the market.

The global animal genetics market has been segmented on the basis of region and product and services. The sole objective of providing such an all-inclusive report is to offer a deep insight into the market.

Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6133

Global Animal Genetics Market: Notable Developments

The global animal genetics market has gone through a few developments in the last few years. These market developments make a manifestation of how and what is influencing the growth of the global animal genetics market. One such development is mentioned below:

Some of the key market players of the global animal genetics market are

Global Animal Genetics Market: Growth Drivers

High Demand for Animal Protein Places the Market on a High Growth Trajectory

The global animal genetics market is estimated to experience considerable growth over the review period. Such stellar growth of the market is attributed to the augmented adoption of genetic technologies and strict implementation of animal welfare regulations.

Likewise, livestock population has witnessed a substantial rise together with awareness related to the existence of animal genetic disorders. Besides, the need to cater to the unmet demands of animal protein is likely to add fillip to the global animal genetics market over the forecast timeframe.

Buy this Premium Report @ https://www.tmrresearch.com/checkout?rep_id=6133&ltype=S

With an objective to produce better milk and food products, there has been an escalation in the research and development activities by several scientists. Genetic modifications are likely to emerge as another factor supporting the expansion of the global animal genetics market in forthcoming years.

The market is also prophesized to be fuelled by rapid expansion of urbanization and rise in population, which place massive demand for animal protein. Increased adoption of various advanced genetic practices like embryo transfer, artificial insemination (AI) for production of modified breed on a large scale is estimated to favor the market in the years to come.

On the other hand, the dearth of properly skilled technicians and professional with expertise in genetic services is estimate to impede the growth of the global animal genetics market in years to come. Furthermore, strict regulations related to genetic engineering of animals together with high cost of animal testing is likely to obstruct the growth of the market.

Global Animal Genetics Market: Regional Outlook

Asia Pacific, the Middle East and Africa, South America, Europe, and North America comprise the major regions of the global animal genetics market.

Considering geographies, North America is likely to play a dominant role in the global animal genetics market over the assessment timeframe. Such regional supremacy is ascribed to the presence of a large number of well-known companies of the global animal genetics market. In addition, the presence of a well-established livestock industry is likely to propel the North America animal genetics market to prominence in the near future.

Get Table of Content of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6133

The global animal genetics market is segmented as:

Products and Services

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

Rohit Bhisey

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Visit Site: https://www.tmrresearch.com/

Read the original post:
Animal Genetics Market | Know the Latest Innovations and Developments in the Market - BioSpace